Order Article Reprints

Striefler JK, Stieler JM, Neumann CCM, Geisel D, Ghadjar P, Sinn M, Malinka T, Pratschke J, Stintzing S, Oettle H, et al. Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation. Journal of Clinical Medicine. 2022; 11(16):4905. https://doi.org/10.3390/jcm11164905

Striefler, Jana K., Jens M. Stieler, Christopher C. M. Neumann, Dominik Geisel, Pirus Ghadjar, Marianne Sinn, Thomas Malinka, Johann Pratschke, Sebastian Stintzing, Helmut Oettle, and et al. 2022. "Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation" Journal of Clinical Medicine 11, no. 16: 4905. https://doi.org/10.3390/jcm11164905

Striefler, J. K., Stieler, J. M., Neumann, C. C. M., Geisel, D., Ghadjar, P., Sinn, M., Malinka, T., Pratschke, J., Stintzing, S., Oettle, H., Riess, H., & Pelzer, U. (2022). Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation. Journal of Clinical Medicine, 11(16), 4905. https://doi.org/10.3390/jcm11164905